NFE2L2 and type 2 diabetes mellitus: In an animal model of non‐obese type 2 diabetes (Goto‐Kakizaki rats), SFN reversed the diabetes‐repressed expression of aortic NRF2, attenuated the production of aortic O2 and AGEs and improved nitric oxide (NO)‐dependent and nitric oxide nitric oxide‐independent vasorelaxation.29